Merck Monday reported a better-than-expected profit, helped by sales of its vaccines and cholesterol drugs, and raised its 2007 profit forecast in view of strong current trends.
"Our third-quarter results reflect the continued progress Merck is making to deliver on our strategy," chief executive officer Richard Clarke said in a statement.
The company said it earned $1.53 billion, or 70 cents per share, compared with $941 million, or 43 cents per share, in the year-ago period when it took $598 million charge for legal expenses related to its withdrawn Vioxx arthritis drug.
Excluding restructuring charges, Merck Merck & Co IncMRK
53.11 UNCH 0% NYSE
Link:
http://www.cnbc.com/id/21375721 
Printer-friendly format
Email this thread to a friend
Bookmark this thread
(1000+ posts)
Send PM |
Profile |
Ignore
